ArticlePathogens (Basel, Switzerland)2025
Longitudinal Trend in Hospital-Wide Syphilis Testing and Clinical Characteristics of Syphilis Requiring Treatment.
Article in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Globally, syphilis cases are rising, and varied symptoms hinder diagnosis, highlighting the role of serological testing. Comprehensive institutional analysis is needed, as many reports are limited. We retrospectively reviewed 23 persons with syphilis treated at Kanazawa University Hospital (January 2007-December 2023). Of 9145 individuals tested for treponemal (chemiluminescent enzyme immunoassay) and nontreponemal (rapid plasma reagin, RPR) antibodies, diagnoses were based on clinical assessment and serology. Data on history, stage, lesions, and treatment were collected. From 2007 to 2023, antibody testing increased, but treated cases stayed stable (0-4/year). Males comprised 60.9% and females 39.1%. In the treated 23 patients, ophthalmology (30.4%) and dermatology (17.4%) accounted for nearly half of test requests, though cases arose across specialties. Early-stage and ocular syphilis each occurred in 34.8%. Uveitis was the most common lesion (26.1%). Treatment included amoxicillin (69.6%) or penicillin (21.7%). At diagnosis, 78.3% were dual-positive and 21.7% treponemal-only positive. Nine patients (64.3%) had a ≥4-fold RPR titer decline (median 143.5 days); no RPR increases suggested treatment failure or reinfection. This study found stable treated numbers, with ocular syphilis and uveitis frequent. In specialized institutions, clinicians should consider syphilis in persons with varied symptoms across departments, ensuring comprehensive testing and appropriate follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.